HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMPACT THERAP-B

36.760

-0.240-0.65%

Volume:1K

Turnover:43.70K

Market Cap:10.38B

PE:-25.51

High:36.800

Open:36.800

Low:36.220

Close:37.000

52wk High:47.980

52wk Low:28.200

Shares:282.46M

HK Float Shares:282.46M

Volume Ratio:0.07

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.441

ROE:--

ROA:-40.35%

PB:-9.36

PE(LYR):-25.51

PS:234.46

Loading ...

Overview Company News Filings

Company Profile

Company Name:

IMPACT THERAP-B

Exchange:

SEHK

Establishment Date:

2009

Employees:

- -

Office Location:

New Bund Times Square,27th Floor,399 West Haiyang Road,Pudong New District,Shanghai,Shanghai Province,China

Website:

http://www.impacttherapeutics.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

IMPACT Therapeutics Inc is a China-based company mainly engaged in biotechnology research and commercialization. The Company is in the commercialization stage. The Company is committed to advancing synthetic lethality (SL)-based precision anti-cancer therapies globally. The Company's independently developed core product, senaparib, in China as a 1L maintenance therapy for ovarian cancer (OC). The Company is currently developing product pipeline packages such as PARP1/2, PARP1, ATR, WEE1, PKMYT1/WEE1, DHX9, ATM, USP1, and CHK1/2.

Directors

Name

Position

XU Cong

Chairman of the Board,Director,Member of the Nomination Committee

CAI Sui Xiong

Executive Director

TIAN Ye

Executive Director

MA Ning

Executive Director,Member of the Nomination Committee

GUO Ming

Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee

XIAO Zhi Xiong

Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Chairman of the Audit Committee

SHAO Li Ming

Independent Director,Chairman of the Nomination Committee

Qiang XU

Director,Member of the Remuneration and Assessment Committee

LIU Tao

Director,Member of the Audit Committee

Shareholders

Name

Position

CAI Sui Xiong

CEO

TIAN Ye

Deputy General Manager,Chief Science Officer

MA Ning

Deputy General Manager

DENG Hui Jun

CFO

HAN Yi Fan

Board Secretary,Corporate Secretary,Other Senior Executives

XIE Cui Mei

Corporate Secretary

XU Yan Hua

Other Senior Executives

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/07630/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"07630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"IMPACT THERAP-B","latestPrice":36.76,"timestamp":1781228934083,"preClose":37,"halted":0,"volume":1200,"delay":0,"changeRate":-0.00648648648648654,"floatShares":282461530,"shares":282461530,"eps":-1.440772,"marketStatus":"Trading","change":-0.24,"latestTime":"06-12 09:50:50","open":36.8,"high":36.8,"low":36.22,"amount":43696,"amplitude":0.015676,"askPrice":36.76,"askSize":400,"bidPrice":36.5,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.16,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1781236800000},"marketStatusCode":2,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":37,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0.068953,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"07630\",,,,,undefined,":{"symbol":"07630","floatShares":282461530,"roa":"-40.35%","roe":"--","lyrEps":-1.440772,"volumeRatio":0.068953,"shares":282461530,"dividePrice":0,"high":36.8,"amplitude":0.015676,"preClose":37,"low":36.22,"week52Low":28.2,"pbRate":"-9.36","psRate":"234.46","week52High":47.98,"institutionHeld":0,"latestPrice":36.76,"committee":-0.333333,"eps":-1.440772,"divideRate":0,"volume":1200,"delay":0,"ttmEps":-1.16,"open":36.8,"prevYearClose":20.1,"prevWeekClose":37.02,"prevMonthClose":39.9,"prevQuarterClose":20.1,"fiveDayClose":37.02,"twentyDayClose":40,"sixtyDayClose":20.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/07630\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"07630\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/07630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"07630","date":"2026-06-10","current":-31.896552,"percent":0.85,"low":-34.323153,"twenty":-32.344912,"median":-30.958502,"eighty":-29.849738,"high":-16.800385,"avg":-30.407128,"sd":3.543955,"marketCap":10135260271},"quantilePoints":[{"date":"2026-05-15","current":-32.36994,"twenty":-32.973318,"median":-32.357426,"eighty":-26.127101,"marketCap":11057651805},{"date":"2026-05-22","current":-30.548005,"twenty":-32.354923,"median":-30.958502,"eighty":-28.393426,"marketCap":10411425401},{"date":"2026-05-29","current":-32.218614,"twenty":-32.294393,"median":-30.958502,"eighty":-30.148817,"marketCap":11018988687},{"date":"2026-06-05","current":-29.849738,"twenty":-32.359929,"median":-31.257987,"eighty":-30.148817,"marketCap":10223633112},{"date":"2026-06-10","current":-29.609087,"twenty":-32.344912,"median":-30.958502,"eighty":-29.849738,"marketCap":10135260271}],"updateTime":1781210326613},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":129927258,"yearFounded":2009,"address":"New Bund Times Square,27th Floor,399 West Haiyang Road,Pudong New District,Shanghai,Shanghai Province,China","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.impacttherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0768},{"period":"1month","weight":0.8408},{"period":"ytd","weight":0.8408}],"compareEarnings":[{"period":"1week","weight":-0.0398},{"period":"1month","weight":-0.0797},{"period":"3month","weight":-0.0478},{"period":"6month","weight":-0.0665},{"period":"1year","weight":-0.0048},{"period":"ytd","weight":-0.0539}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"IMPACT Therapeutics Inc is a China-based company mainly engaged in biotechnology research and commercialization. The Company is in the commercialization stage. The Company is committed to advancing synthetic lethality (SL)-based precision anti-cancer therapies globally. The Company's independently developed core product, senaparib, in China as a 1L maintenance therapy for ovarian cancer (OC). The Company is currently developing product pipeline packages such as PARP1/2, PARP1, ATR, WEE1, PKMYT1/WEE1, DHX9, ATM, USP1, and CHK1/2.","exchange":"SEHK","name":"IMPACT THERAP-B","nameEN":"IMPACT THERAP-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"07630\",market:\"HK\",,,undefined,":{"directors":[{"name":"XU Cong","position":"Chairman of the Board,Director,Member of the Nomination Committee"},{"name":"CAI Sui Xiong","position":"Executive Director"},{"name":"TIAN Ye","position":"Executive Director"},{"name":"MA Ning","position":"Executive Director,Member of the Nomination Committee"},{"name":"GUO Ming","position":"Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee"},{"name":"XIAO Zhi Xiong","position":"Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Chairman of the Audit Committee"},{"name":"SHAO Li Ming","position":"Independent Director,Chairman of the Nomination Committee"},{"name":"Qiang XU","position":"Director,Member of the Remuneration and Assessment Committee"},{"name":"LIU Tao","position":"Director,Member of the Audit Committee"}],"executives":[{"name":"CAI Sui Xiong","position":"CEO"},{"name":"TIAN Ye","position":"Deputy General Manager,Chief Science Officer"},{"name":"MA Ning","position":"Deputy General Manager"},{"name":"DENG Hui Jun","position":"CFO"},{"name":"HAN Yi Fan","position":"Board Secretary,Corporate Secretary,Other Senior Executives"},{"name":"XIE Cui Mei","position":"Corporate Secretary"},{"name":"XU Yan Hua","position":"Other Senior Executives"}]}}}